Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor coactivator 4 pseudogene 3 (NCOA4P3) is a genomic pseudogene similar in sequence to the nuclear receptor coactivator 4 gene (NCOA4) but is regarded as non-functional. It is not translated into protein, does not act as a receptor, enzyme, transporter, or transcription factor, and is not associated with biological functions, disease roles, or drug interactions. NCOA4P3 is thus not considered a therapeutic target, and its entry may reflect a nomenclature artifact rather than a biologically relevant molecule[5][7]. If you are seeking information about the functional NCOA4 gene (nuclear receptor coactivator 4), it is a well-characterized coactivator involved in steroid hormone receptor signaling, cell division, cancer biology, and iron metabolism[3][5][7]. In contrast, NCOA4P3 is a pseudogene and does not share these properties.
None (no mechanism, as this is a non-coding pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor coactivator 4 pseudogene 3 (NCOA4P3).